Tags
Results for: Hourigan Lab
-
Article Item
Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds , articlePatients in remission after battling blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells. The finding in JAMA Oncology emphasizes the importance of testing for lingering cancer cells in the body after people receive apparently successful chemotherapy treatment.
Date: May 02, 2024 -
Video ItemEminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , video
Christopher Hourigan will spearhead innovative cancer solutions at the Fralin Biomedical Research Institute Cancer Research Center in the nation's capital.
Date: Apr 10, 2024 -
Article Item
Virginia Tech professor to be inducted into prestigious American Society for Clinical Investigation , articleChristopher Hourigan, director of the Cancer Research Center – D.C., has been inducted into the American Society for Clinical Investigation, a historic membership for a faculty member of Virginia Tech.
Date: Apr 04, 2024 -
Article Item
Eminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , articleA National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan is joining Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.
Date: Apr 01, 2024